Search Results - "Forti, Elisa"
-
1
Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages
Published in Journal of hepatology (01-01-2017)“…Graphical abstract…”
Get full text
Journal Article -
2
Dysregulation of Iron Metabolism in Cholangiocarcinoma Stem-like Cells
Published in Scientific reports (15-12-2017)“…Cholangiocarcinoma (CCA) is a devastating liver tumour arising from malignant transformation of bile duct epithelial cells. Cancer stem cells (CSC) are a…”
Get full text
Journal Article -
3
P1208: TRANSCRIPTOMIC PROFILING OF B CELL STATES AND MICROENVIROMENTAL ECOSYSTEMS REFINES THE PROGNOSTIC CLASSIFICATION OF DIFFUSE LARGE B CELL LYMPHOMA
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
4
Clinico-Pathological, Cytogenetic and Molecular Similarities and Differences between Primary and Secondary Cutaneous Lymphomas
Published in Blood (15-11-2022)Get full text
Journal Article -
5
Clinicopathological, cytogenetic, and molecular profiles of primary cutaneous diffuse large B-cell lymphomas
Published in Human pathology (01-06-2023)“…We analyzed the clinicopathological, cytogenetic, and molecular features of 18 primary cutaneous diffuse large B-cell lymphomas (PCDLBCLs) and 15 DLBCLs…”
Get full text
Journal Article -
6
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma
Published in The American journal of pathology (01-10-2019)“…Fibroblast growth factor receptor 2 (FGFR2) might have an important role in the pathogenesis and biology of cholangiocarcinoma (CCA). We examined FGFR…”
Get full text
Journal Article -
7
A new digital droplet PCR method for looking at epigenetics in diffuse large B-cell lymphomas: The role of BMI1, EZH2, and USP22 genes
Published in International journal of laboratory hematology (10-09-2024)“…Epigenetics has been shown to be relevant in oncology: BMI1 overexpression has been reported in leukemias, EZH2 mutations have been found in follicular…”
Get full text
Journal Article -
8
Abstract 2677: Role of CLEC4D in inflammation-driven liver carcinogenesis
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Abstract Hepatocellular carcinoma (HCC) accounts for approximately 90% of all primary liver tumors and is the second most deadly cancer in the world. HCC…”
Get full text
Journal Article -
9
COO, MYC / BCL2 Status and R-IPI Define a Group of Poor Prognosis DLBCL Patients in a Real-World Clinical Setting
Published in Blood (13-11-2019)“…BACKGROUND In DLBCL, and mainly in advanced-stage, the presence of an activated B-cell phenotype or a non-GCB phenotype, and the coexpression of Myc and Bcl2…”
Get full text
Journal Article -
10
-
11
Prognostication of Diffuse Large B-Cell Lymphoma By Lympho2Cx Assay and BCL2 and MYC Expression: Application in a Real Life Context of 154 Patients
Published in Blood (29-11-2018)“…BACKGROUND: About one third of patients with diffuse large B-cell lymphoma (DLBCL) eventually die from their disease. Thus, it is extremely important to…”
Get full text
Journal Article -
12
Feasibility of pig and human-derived aortic valve interstitial cells seeding on fixative-free decellularized animal pericardium
Published in Journal of biomedical materials research. Part B, Applied biomaterials (01-02-2016)“…Glutaraldehyde-fixed pericardium of animal origin is the elective material for the fabrication of bio-prosthetic valves for surgical replacement of…”
Get full text
Journal Article